Drugs / Natriumfolinate
last change May 2020 re-read 2 minutes ago

Natriumfolinate

Developed for
pancreatic exocrine neoplasm
Investigated by
Krankenhaus Nordwest

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT02172976 Nov 2014 → Jan 2020 pancreatic exocrine neoplasm Krankenhaus Nordwest Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Natriumfolinate ClinicalTrials.gov intervention name — accepted as the source's own label NCT02172976